Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
11th March 2024 • Oncology Today with Dr Neil Love • Research To Practice
00:00:00
00:37:37